共 116 条
- [111] YANG Z, WANG J, LU Q, Et al., PEGylation confers greatly extended half-life and attenuated immunogenicity to recombinant methioninase in primates, Cancer Research, 64, 18, pp. 6673-6678, (2004)
- [112] KAWAGUCHI K, HAN Q, LI S, Et al., Targeting methionine with oral recombinant methioninase (o-rMETase) arrests a patient-derived orthotopic xenograft (PDOX) model of BRAF-V600E mutant melanoma: implications for chronic clinical cancer therapy and prevention, Cell Cycle, 17, 3, pp. 356-361, (2018)
- [113] TASHIRO Y, HAN Q, TAN Y, Et al., Oral recombinant methioninase prevents obesity in mice on a high-fat diet, In Vivo, 34, 2, pp. 489-494, (2020)
- [114] HAN Q H, HOFFMAN R M., Chronic treatment of an advanced prostate-cancer patient with oral methioninase resulted in long-term stabilization of rapidly rising PSA levels, In Vivo, 35, 4, pp. 2171-2176, (2021)
- [115] HAN Q H, TAN Y Y, HOFFMAN R M., Oral dosing of recombinant methioninase is associated with a 70% drop in PSA in a patient with bone-metastatic prostate cancer and 50% reduction in circulating methionine in a high-stage ovarian cancer patient, Anticancer Research, 40, 5, pp. 2813-2819, (2020)
- [116] HARTMANN R, MEISEL H., Food-derived peptides with biological activity: from research to food applications, Current Opinion in Biotechnology, 18, 2, pp. 163-169, (2007)